NCT01204528View on ClinicalTrials.gov

Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions
Chronic Kidney Disease
Interventions
DRUG

Zemplar

Vitamin D receptor activator (VDRA)

Trial Locations (1)

18288

Karolinska Institute at Danderyd University Hospital, Danderyd

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Danderyd Hospital

OTHER

NCT01204528 - Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease | Biotech Hunter | Biotech Hunter